| Regeneration of B cell subsets after transient B cell depletion using anti‐CD20 antibodies in rheumatoid arthritis P Roll, A Palanichamy, C Kneitz, T Dorner, HP Tony Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 366 | 2006 |
| Novel human transitional B cell populations revealed by B cell depletion therapy A Palanichamy, J Barnard, BO Zheng, T Owen, T Quach, C Wei, ... The Journal of Immunology 182 (10), 5982-5993, 2009 | 332 | 2009 |
| Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients A Palanichamy, S Jahn, D Nickles, M Derstine, A Abounasr, SL Hauser, ... The Journal of Immunology 193 (2), 580-586, 2014 | 273 | 2014 |
| Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis A Palanichamy, L Apeltsin, TC Kuo, M Sirota, S Wang, SJ Pitts, ... Science translational medicine 6 (248), 248ra106-248ra106, 2014 | 246 | 2014 |
| B cells in the pathogenesis and treatment of rheumatoid arthritis B Marston, A Palanichamy, JH Anolik Current opinion in rheumatology 22 (3), 307, 2010 | 193 | 2010 |
| Expansion of activated peripheral blood memory B cells in rheumatoid arthritis, impact of B cell depletion therapy, and biomarkers of response DG Adlowitz, J Barnard, JN Biear, C Cistrone, T Owen, W Wang, ... PloS one 10 (6), e0128269, 2015 | 142 | 2015 |
| Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus A Palanichamy, JW Bauer, S Yalavarthi, N Meednu, J Barnard, T Owen, ... The Journal of Immunology 192 (3), 906-918, 2014 | 110 | 2014 |
| Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targets H von Büdingen, A Palanichamy, K Lehmann-Horn, BA Michel, SS Zamvil European neurology 73 (3-4), 238-246, 2015 | 88 | 2015 |
| Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody AS Rouzière, C Kneitz, A Palanichamy, T Dörner, HP Tony Arthritis research & therapy 7 (4), 1-11, 2005 | 64 | 2005 |
| Small molecule mediated inhibition of RORγ‐dependent gene expression and autoimmune disease pathology in vivo D Banerjee, L Zhao, L Wu, A Palanichamy, A Ergun, L Peng, C Quigley, ... Immunology 147 (4), 399-413, 2016 | 46 | 2016 |
| Modulation of molecular imprints in the antigen‐experienced B cell repertoire by rituximab A Palanichamy, P Roll, R Theiss, T Dörner, HP Tony Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 22 | 2008 |
| Intrathecal B-cell activation in LGI1 antibody encephalitis K Lehmann-Horn, SR Irani, S Wang, A Palanichamy, S Jahn, ... Neurology-Neuroimmunology Neuroinflammation 7 (2), 2020 | 21 | 2020 |
| Failure of B cell tolerance in CVID CT Richardson, MA Slack, G Dhillon, CZ Marcus, J Barnard, ... Frontiers in Immunology 10, 2881, 2019 | 12 | 2019 |
| Collagen turnover biomarkers associate with active psoriatic arthritis and decrease with guselkumab treatment in a phase 3 clinical trial (DISCOVER-2) G Schett, MJ Loza, A Palanichamy, O FitzGerald, C Ritchlin, ... Rheumatology and Therapy 9 (4), 1017-1030, 2022 | 11 | 2022 |
| Rituximab therapy leads to reduced imprints of receptor revision in immunoglobulin κ and λ light chains A Palanichamy, K Muhammad, P Roll, S Kleinert, T Dörner, HP Tony The Journal of Rheumatology 39 (6), 1130-1138, 2012 | 6 | 2012 |
| B cell regeneration after B cell depletion with rituximab in patients with rheumatoid arthritis: Transient recirculation of plasmablasts and increased levels of germinal center … P Roll, A Palanichamy, AS Rouziere, T Dörner, C Kneitz, HP Tony ARTHRITIS AND RHEUMATISM 52 (9), S289-S289, 2005 | 6 | 2005 |
| Characterization of human late transitional B cells: Implications for systemic lupus A Palanichamy, J Barnard, T Owen, B Zheng, T Conley, T Quach, C Wei, ... ARTHRITIS AND RHEUMATISM 58 (9), S446-S446, 2008 | 3 | 2008 |
| Interferon activation in human SLE bone marrow inhibits B cell lymphopoiesis J Barnard American College of Rheumatology National Meeting 2008, 2008 | 2 | 2008 |
| Effect of Ocrelizumab on B-and T-Cell Receptor Repertoire Diversity in Patients With Relapsing Multiple Sclerosis From the Randomized Phase III OPERA Trial SA Laurent, NB Strauli, EL Eggers, H Wu, B Michel, S Demuth, ... Neurology-Neuroimmunology Neuroinflammation 10 (4), 2023 | 1 | 2023 |
| Impact of Anti Tumor Necrosis Factor-Alpha Therapy in Rheumatoid Arthritis On Osteoclast Activation and B Cells. E Ezealah, J Hossler, J Biear, CA Cistrone, T Owen, N Meednu, ... ARTHRITIS AND RHEUMATISM 64 (10), S516-S516, 2012 | 1 | 2012 |
